Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Diagnosis, management, and treatment of hepatitis C: An update
- M. Ghany, D. Strader, D. Thomas, L. Seeff
- Medicine
- Hepatology
- 1 April 2009
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology.
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
- R. Sterling, E. Lissen, +9 authors M. Nelson
- Medicine
- Hepatology
- 1 June 2006
Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy.… Expand
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- D. Thomas, C. Thio, +16 authors M. Carrington
- Biology, Medicine
- Nature
- 8 October 2009
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, with estimates of 4 million HCV-infected individuals in the United States and 170 million worldwide.… Expand
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
- S. Khakoo, C. Thio, +15 authors M. Carrington
- Biology, Medicine
- Science
- 6 August 2004
Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of… Expand
Multimodal population brain imaging in the UK Biobank prospective epidemiological study
- K. Miller, F. Alfaro-Almagro, +18 authors S. Smith
- Psychology, Medicine
- Nature Neuroscience
- 12 September 2016
Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem… Expand
Genetic epidemiology of hepatitis C virus throughout egypt.
- S. Ray, R. Arthur, A. Carella, J. Bukh, D. Thomas
- Biology, Medicine
- The Journal of infectious diseases
- 1 September 2000
Hepatitis C virus (HCV) infection is a major health problem in Egypt, where the seroprevalence is 10-20-fold higher than that in the United States. To characterize the HCV genotype distribution and… Expand
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
- M. Ghany, D. Nelson, D. Strader, D. Thomas, L. Seeff
- Medicine
- Hepatology
- 1 October 2011
The standard of care (SOC) therapy for patients with chronic hepatitis C virus (HCV) infection has been the use of both peginterferon (PegIFN) and ribavirin (RBV). These drugs are administered for… Expand
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
- M. Sulkowski, D. Thomas, R. E. Chaisson, R. Moore
- Medicine
- JAMA
- 5 January 2000
CONTEXT
Use of antiretroviral drugs, including protease inhibitors, for treatment of human immunodeficiency virus (HIV) infection has been anecdotally associated with hepatotoxicity, particularly in… Expand
Occult hepatitis B.
- M. Torbenson, D. Thomas
- Medicine
- The Lancet. Infectious diseases
- 1 August 2002
Worldwide, chronic hepatitis B virus (HBV) infection is the primary cause of cirrhosis and hepatocellular carcinoma and is one of the ten leading causes of death. Traditionally, people with chronic… Expand
Diagnosis, management, and treatment of hepatitis C
- D. B. Strader, T. Wright, D. Thomas, L. Seeff
- Medicine
- Hepatology
- 1 April 2004
These recommendations provide a data-supported approach. They are based on the following: (1) a formal review and analysis of the recently published world literature on the topic (Medline search);… Expand